Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Computing
Conference & Expo
November 2-4, 2009 NYC
Register Today and SAVE !..

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
SYS-CON.TV
The ALS Association Announces New Research Awards to Focus on Therapies for Lou Gehrig's Disease

WASHINGTON, Nov. 30, 2012 /PRNewswire-USNewswire/ -- The ALS Association will add ten awards totaling $2.9 million to its Translational Research Advancing Therapies for ALS (TREAT ALS™) portfolio, funding two clinical management grants, three drug discovery contracts, two clinical pilot studies and three biomarker studies—all focused on finding improved treatments for people with amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's disease. The ALS Association's TREAT ALS ™ portfolio presently has 80 active research projects with a total award value of $12 million.

Due to the deadly and often rapid nature of ALS, a need exists for treatments and a cure for this disease as there is only one drug approved by the U.S. Food and Drug Administration (FDA) that modestly extends survival. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. For unknown reasons, veterans are twice as likely to develop ALS as the general population.

The two clinical management grants, which intend to expand access to care for people with ALS will analyze remote forms of treatments. Edward Kasarskis, M.D., and Richard Kryscio, Ph.D., with the University of Kentucky Research Foundation in Lexington, Ky. will devise and monitor a virtual ALS center that could provide people with the disease with multidisciplinary care remotely in their homes. James Berry, M.D., and Merit Cudkowicz, M.D., with the Massachusetts General Hospital in Boston, Mass. have devised a "telehealth" initiative to assess a videoconferencing program that offers home health providers tools to provide care to people with ALS in homes.

The three drug discovery contracts awarded by The ALS Association will support the pre-clinical assessment of therapeutics for the disease, and researchers expect they will lead to the progress of new therapies for ALS. Researchers leading these projects include: Oleg Butovsky, Ph.D., with Brigham and Women's Hospital in Boston, Mass.; Steven Burden, Ph.D., with Skirball Institute, New York University Medical School, in New York; and Rita Sattler, Ph.D., and Jeffrey Rothstein, M.D., Ph.D., at Johns Hopkins University School of Medicine in Baltimore, Maryland.

In addition to the clinical management grants and drug discovery contracts, The ALS Association is supporting two novel clinical pilot studies involving people with ALS with the Northeast ALS Consortium (NEALS) Clinical Trials Network. Jonathan Glass, M.D., and Christina Fournier, M.D., with Emory University in Atlanta, along with Merit Cudkowicz, M.D., and James Berry M.D., in Boston, Mass. will work together to determine whether they can identify a subset of people with ALS that respond to immune suppressing medication. Additionally, Jeremy Shefner, M.D., Ph.D., with SUNY Upstate Medical University in Syracuse, N.Y. will test Cogane™, a small, non-peptide agent that can penetrate the brain and spinal cord, which has been shown to improve the number of functional motor units and increased the life span in mouse models of ALS.

The ALS Association will also fund three biomarker studies, which could accelerate diagnosis of the disease and hasten clinical trials. Two of the three studies were supported by EMD/ALS Biomarker Research Fund through the Keith Worthington Chapter of The ALS Association.  Researchers include Michael Benatar, M.D., and Joanne Wuu, both with the University of Miami Miller School of Medicine in Miami, Fla., who will look for predictive biomarkers in patients with a genetic form of the disease before they develop symptoms. Patricia Anders, MHG, Boston, Mass. will develop a strength testing device that may more accurately measure response to therapy.  And finally, Lyl Ostrowe, M.D., Ph.D.; Dean Wong, M.D., Ph.D. and Jeffrey Rothstein, M.D., Ph.D., all with Johns Hopkins University, will assess whether a PET imaging marker can accurately distinguish between people with ALS and healthy subjects.

To view a full listing of these awards, please visit www.alsa.org/researchawards2012.

About The ALS Association

The ALS Association is the only national non-profit organization fighting Lou Gehrig's Disease on every front.  By leading the way in global research, providing assistance for people with ALS through a nationwide network of chapters, coordinating multidisciplinary care through certified clinical care centers, and fostering government partnerships, The Association builds hope and enhances quality of life while aggressively searching for new treatments and a cure.  For more information about The ALS Association, visit our website at www.alsa.org.

SOURCE The ALS Association

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

SOA World Latest Stories
The definition of IoT is not new, in fact it’s been around for over a decade. What has changed is the public's awareness that the technology we use on a daily basis has caught up on the vision of an always on, always connected world. If you look into the details of what comprises the I...
The 4th International DevOps Summit, co-located with16th International Cloud Expo – being held June 9-11, 2015, at the Javits Center in New York City, NY – announces that its Call for Papers is now open. Born out of proven success in agile development, cloud computing, and process aut...
Verizon Enterprise Solutions is simplifying the cloud-purchasing experience for its clients, with the launch of Verizon Cloud Marketplace, a key foundational component of the company's robust ecosystem of enterprise-class technologies. The online storefront will initially feature pre-b...
To manage complex web services with lots of calls to the cloud, many businesses have invested in Application Performance Management (APM) and Network Performance Management (NPM) tools. Together APM and NPM tools are essential aids in improving a business's infrastructure required to s...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle ...
What’s Big Data without Big Compute? Basically just a large collection of unstructured information with little purpose and value. It’s not enough for data just to exist, we must derive value from it through computation – something commonly referred to as analytics. With traditional ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE